WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia / World Health Organization.

Format:

Book

Author/Creator:

World Health Organization, author, issuing body.

Language:

English

Subjects (All):

Preeclampsia.

Therapeutics.

Physical Description:

1 online resource (viii, 70 pages) : illustrations

Edition:

1st ed.

Place of Publication:

Geneva, Switzerland : World Health Organization, 2021.

Summary:

This is an update to recommendations related to the use of anti-platelet agents for the prevention of pre-eclampsia. The recommendation in this document thus supersedes the previous WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia as published in the 2011 guidelines, WHO recommendations for the prevention and treatment of pre-eclampsia and eclampsia. The recommendation now specifies the use of anti-platelet agents in women at moderate and high risk of pre-eclampsia to prevent the development of pre-eclampsia. The primary audience for these recommendations includes health professionals who are responsible for developing national and local health-care guidelines and protocols and those involved in the provision of care to women and their newborns during pregnancy, labour and childbirth, including midwives, nurses, general medical practitioners and obstetricians. The primary audience also includes managers of maternal and child health programmes, and relevant staff in ministries of health and educational and training institutions, in all settings.

Notes:

Includes bibliographical references.

Description based on: online resource; title from PDF information screen (NCBI, viewed November 06, 2022).